Drug Trial Radar · NCT01452464
Safety of MenACWY-CRM Vaccination in Adolescents
Last checked: Nov 19, 2026Latest source record: Feb 26, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
55,397
Actual
Start
Sep 2011
Primary completion
Feb 2015
Study completion Feb 2015
Sponsor
- Lead sponsor
- Novartis VaccinesNovartis (NVS)
- Sponsor type
- Industry
- Collaborators
- Novartis
- First posted
- Oct 14, 2011
Design
- Study type
- Observational
- Who can join
- All sexes, from 11 years, up to 21 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this US FDA post-marketing commitment study is to evaluate the safety of MenACWY-CRM among 50.000 vaccinated adolescents within a large US Healthcare Maintenance Organization who received MenACWY-CRM vaccination as part of their routine clinical care. The pre-specified 26 events of interest are events commonly evaluated in vaccine safety studies and include certain neurological, immunological, vascular, musculoskeletal and hematologic disorders. All events are collected retrospectively.
Conditions
- Meningococcal Disease
Interventions
MenACWY-CRMBiological
MenACYW-CRM vaccination received as part of routine clinical care and as registered in the vaccine records.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Relative incidence (RI) for an Event of Interest (EOI) is calculated using the self controlled case series method. RI is the ratio of the incidence of an EOI in a pre-specified, event-specific risk window relative to the incidence in the control period.Time frame: Observational period of 1 year following date of vaccination of that individual.
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Riverside Medical Center Campus, 10800 Magnolia Ave
Riverside, California
San Diego Medical Center Campus, 4647 Zion Ave 92120
San Diego, California
Fontana Medical Center Campus
Valley Annex, 16994 E. Valley Blvd., Fontana, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.